DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20220199

Саse reроrt оf fetal liver cirrhosis due to gestational alloimmune liver disease in а primigravida femаle, in north east region of India

Priya Gupta, Sandip Maheshwari

Abstract


Fetal liver failure is a major cause of neonatal morbidity and mortality, presenting as acute liver failure and/or congenital cirrhosis. There are several causes of fetal liver failure and early diagnosis is mandatory to elucidate the etiology and determine a specific treatment or the best management strategy. Gestational alloimmune liver disease associated with neonatal hemochromatosis (GALD-NH) is a rare cause of fetal liver failure. It should be considered in any neonate with fetal signs of liver failure with no other identifiable causes. GALD-NH is often diagnosed late and patients are therefore referred late to specialized centers, delaying treatment. This case highlighted the consequences of late diagnosis and treatment of GALD-NH and emphasizes the importance of a high grade of suspicion of this disease in order to refer the patient to a specialized center soon enough to perform the appropriate treatment.


Keywords


Neonatal hemochromatosis, Fetal liver failure, Gestational alloimmune liver disease

Full Text:

PDF

References


Bitar R, Thwaites R, Davison S, Rajwal S, McClean P. Liver Failure in Early Infancy: Aetiology, Presentation, and Outcome. J Pediatr Gastroenterol Nutr. 2017;64(1):70-5.

Feldman AG, Whitington PF. Neonatal hemochromatosis. J Clin Exp Hepatol. 2013;3(4):313-20.

Feldman AG, Whitington PF. Neonatal hemochromatosis. J Clin Exp Hepatol. 2013;3(4):313-20.

Shanmugam NP, Bansal S, Greenough A, Verma A, Dhawan A. Neonatal liver failure: aetiologies and management--state of the art. Eur J Pediatr. 2011;170(5):573-81.

Chevret L, Durand P, Lambert J, Essouri S, Balu L, Devictor D, et al. High-volume hemofiltration in children with acute liver failure*. Pediatr Crit Care Med. 2014;15(7):300-5.

Nicastro E, Iorio R. Neonatal hemochromatosis and exchange transfusion: treating the disorder as an alloimmune disease. J Pediatr Gastroenterol Nutr. 2010;50(5):471-2.

Lopriore E, Mearin ML, Oepkes D, Devlieger R, Whitington PF. Neonatal hemochromatosis: management, outcome, and prevention. Prenat Diagn. 2013;33(13):1221-5.

Rand EB, Karpen SJ, Kelly S, Mack CL, Malatack JJ, Sokol RJ, et al. Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin. J Pediatr. 2009;155(4):566-71.

Laet, C, Leonard VJV. Recommendations for the management of tyrosinaemia type 1. Orphanet J Rare Dis. 2013;8(8).

Berry GT. Galactosemia: when is it a newborn screening emergency?. Mol Genet Metab. 2012;106(1):7-11.

Debray FG, Halleux V, Guidi O, Detrembleur N, Gaillez S, Rausin L, et al. Neonatal liver cirrhosis without iron overload caused by gestational alloimmune liver disease. Pediatrics. 2012;129(4):1076-9.

Whitington PF. Gestational alloimmune liver disease and neonatal hemochromatosis. Semin Liver Dis. 2012;32(4):325-32.

Taylor SA, Whitington PF. Neonatal acute liver failure. Liver Transpl. 2016;22(5):677-85.